SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001811764-23-000011
Filing Date
2023-04-27
Accepted
2023-04-27 08:30:44
Documents
6
Period of Report
2023-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A pointbiopharmaglobalinc-20.htm DEF 14A 496308
2 picture1a.jpg GRAPHIC 115488
3 picture2a.jpg GRAPHIC 122640
4 pointlogonewa.jpg GRAPHIC 29832
5 signature-billa.jpg GRAPHIC 2562
6 signature-joea.jpg GRAPHIC 84117
  Complete submission text file 0001811764-23-000011.txt   980999
Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (317) 543-9957
POINT Biopharma Global Inc. (Filer) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39373 | Film No.: 23852101
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences